A case of bullous pemphigoid associated with autoantibodies targeting antigenic sites other than the NC16a domain of BP180

Clinical and Experimental Dermatology

Volumn 30, Issue 5, 2005, Pages 503-505

  Shinojima, Yui ^a   Ochiai, T ^a   Kawamura, A ^a   Arakawa, H ^a   Fukuda, K ^a   Hashimoto, T ^b  

^a SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^b KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; BP180 ANTIBODY; BP180 ANTIGEN; IMMUNOGLOBULIN ANTIBODY; IMMUNOGLOBULIN G; PREDNISOLONE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOBLOTTING; LABORATORY TEST; MALE; MUCOUS MEMBRANE PEMPHIGOID; PEMPHIGOID; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN BIOPSY;

AUTOANTIBODIES; AUTOANTIGENS; HUMANS; IMMUNOGLOBULIN G; KERATINOCYTES; MALE; MIDDLE AGED; PEMPHIGOID, BULLOUS;

EID: 23044460319     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2005.01819.x     Document Type: Article

References (10)

1. Liu Z, Diaz LA, Troy JL et al. A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest 1993; 92: 2480-8.
2. Matsumura K, Amagai M, Nishikawa T et al. The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996; 288: 507-9.
3. Zillikens D, Mascaro JM, Rose PA et al. A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997; 109: 679-83.
4. Schmidt E, Obe K, Brocker EB et al. Serum level of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-8.
5. Kobayashi M, Amagai M, Kuroda-Kinoshita K et al. BP180 ELISA using bacterial recombinant NC16a protein as a diagnostic and monitoring tool for bullous pemphigoid. J Dermatol Sci 2002; 30: 224-32.
6. Nakatani C, Muramatsu T, Shirai T. Immunoreactivity of bullous pemphigoid (BP) autoantibodies against the NC16A and C-terminal domains of the 180kDa BP antigen (BP180): immunoblot analysis and enzyme-linked immunosorbent assay using BP180 recombinant proteins. Br J Dermatol 1998; 139: 365-70.
7. Perriard J, Jaunin F, Favre B et al. IgG autoantibodies from bullous pemphigoid (BP) patients bind antigenic site on both the extracellular and the intracellular domains of the BP antigen 180. J Invest Dermatol 1999; 112: 141-7.
8. Schumann H, Baetge J, Tasanen K et al. The shed ectodomain of collagen BP180 is targeted by autoantibodies in different blistering skin disease. Am J Pathol 2000; 156: 685-95.
9. Di Zenzo G, Grosso F, Terracina M et al. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004; 122: 103-10.
10. 2 and COOH terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119: 1065-73.